References
- Stevenson CL, Bennett DB, Lechuga-Ballesteros D. Pharmaceutical liquid crystals: the relevance of partially ordered systems. J Pharm Sci. 2005;94:1861–1880. doi:10.1002/jps.20435.
- Bunjes H, Rades T. Thermotropic liquid crystalline drugs. J Pharma Pharmacol. 2005;57:807–816. doi:10.1211/0022357056208.
- Hamley IW. Liquid crystal phase formation by biopolymers. Soft Matter. 2010;6:1863–1871. doi:10.1039/b923942a.
- Livolant F, Leforestier A. Condensed phases of DNA: structures and phase transitions. Prog Polym Sci. 1996;21:1115–1164. doi:10.1016/S0079-6700(96)00016-0.
- Giraud-Guille MM, Mosser G, Belamie E. Liquid crystallinity in collagen systems in vitro and in vivo. Curr Opin Colloid Interf Sci. 2008;13:303–313. doi:10.1016/j.cocis.2008.03.002.
- Tang NG, Du G, Wang N, Liu C, Hang HW, Liang W. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. J Natl Cancer Inst. 2007;99:1004–1015. doi:10.1093/jnci/djm027.
- Yoshizawa A, Takahashi Y, Terasawa R, Chiba S, Takahashi K, Hazawa M, Kashiwakura I. Liquid crystallinity and biological activity of a novel amphiphilic compound. Chem Lett. 2009;38:310–311. doi:10.1246/cl.2009.310.
- Yoshizawa A, Takahashi Y, Nishizawa A, Takeuchi K, Sagisaka M, Takahashi K, Hazawa M, Kashiwakura I. Biological activity of some cyanobiphenyl derivatives. Chem Lett. 2009;38:530–531. doi:10.1246/cl.2009.530.
- Fukushi Y, Yoshino H, Ishikawa J, Sagisaka M, Kashiwakura I, Yoshizawa A. Synthesis and anticancer properties of phenyl benzoate derivatives possessing a terminal hydroxyl group. J Mater Chem B. 2014;2:1335–1343. doi:10.1039/c3tb21736a.
- Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem. 2000;43:3867–3877. doi:10.1021/jm000292e.
- Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev. 2011;63:161–169. doi:10.1016/j.addr.2010.09.003.